Clinical Trials

440 enrolled

Multiple Myeloma, Recurrence

NCT05455320 2026-04-13

MonumenTAL-3

864 enrolled

Multiple Myeloma, Recurrence

NCT05572515 2026-04-13

MajesTEC-9

614 enrolled

Multiple Myeloma, Recurrence

NCT05552976 2026-04-01

SUCCESSOR-2

606 enrolled

Multiple Myeloma, Recurrence

NCT05519085 2026-03-24

SUCCESSOR-1

810 enrolled

Multiple Myeloma, Recurrence

NCT07138209 2026-02-27

A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma

228 enrolled

Multiple Myeloma, Recurrence

NCT03539744 2025-06-19

A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

265 enrolled

Other hematologic neoplasm

Multiple Myeloma, Neoplasms, Recurrence

NCT03765541 2025-04-10

DEXAML-03

Phase 3 Terminated

73 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT06561854 2024-12-18

FREEDOM

318 enrolled

Multiple Myeloma, Recurrence

NCT03836014 2024-12-06

CONFIRM

436 enrolled

Multiple Myeloma, Recurrence

NCT03110562 2024-08-21

BOSTON

402 enrolled 22 charts 3 FDA

Multiple Myeloma, Recurrence

NCT03859427 2024-08-13

ARROW2

454 enrolled 24 charts

Multiple Myeloma, Recurrence, Bone Marrow Neoplasms

NCT06232707 2024-05-31

ALUMMINATE

Phase 3 Withdrawn

Multiple Myeloma, Recurrence

NCT03651128 2022-12-15

KarMMa-3

381 enrolled

Multiple Myeloma, Recurrence

NCT03029234 2022-05-25

Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple Myeloma

126 enrolled 30 charts

Multiple Myeloma, Recurrence

NCT05236621 2022-02-11

A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

Phase 3 Unknown

85 enrolled

Multiple Myeloma, Recurrence

NCT01712789 2022-01-10

STRATUS

682 enrolled 23 charts

Multiple Myeloma, Recurrence

NCT00256776 2021-10-18

MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation

Phase 3 Terminated

269 enrolled 9 charts

Multiple Myeloma, Recurrence

NCT01023308 2020-03-17

PANORAMA-1

767 enrolled 17 charts

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

NCT01470131 2018-12-19

A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple Myeloma

Phase 3 Terminated

147 enrolled

Multiple Myeloma, Recurrence

NCT01311687 2018-10-24

NIMBUS

455 enrolled 38 charts

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

NCT03623087 2018-08-14

SIMPLE Chemotherapy for NK Lymphoma/Leukaemia

Phase 3 Unknown

68 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Recurrence

NCT00056160 2017-10-19

CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma

353 enrolled 12 charts

Multiple Myeloma, Recurrence

NCT01449344 2017-03-07

(R-HAD)

Phase 3 Unknown

128 enrolled

Lymphoid

Recurrence, Lymphoma, Mantle-Cell

NCT01266811 2013-01-28

A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Phase 3 Withdrawn

Multiple Myeloma, Recurrence

NCT00478777 2011-11-03

A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma

150 enrolled 9 charts

Multiple Myeloma, Recurrence

NCT00179647 2010-03-16

Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma

1,913 enrolled 8 charts